Targeting RSK2 in Myeloid Leukemia: Right for FLT3 but Wrong for BCR-ABL
Cell Cycle - United States
doi 10.4161/cc.10.21.17833
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
Informa UK Limited
Available in full text
November 1, 2011
Informa UK Limited